These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4929795)

  • 41. [Studies with nitrofurantoin: bacteriological studies with microorganisms causing urinary tract infections].
    Hein H
    Arzneimittelforschung; 1969 Sep; 19(9):1579-84. PubMed ID: 4981210
    [No Abstract]   [Full Text] [Related]  

  • 42. [Application of HI-56 (ampicillin-dicloxacillin) to urological infections (author's transl)].
    Matsumura T; Ando T; Saito T
    Jpn J Antibiot; 1974 Aug; 27(4):556-65. PubMed ID: 4612195
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experimental evaluation of the new cephalosporin antibiotic cephacetrile].
    Kradolfer F; Ahrens T; Gelzer J; Vischer W; Zimmermann W
    Arzneimittelforschung; 1974 Sep; 24(9b):1446-51. PubMed ID: 4154769
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparison of in vitro activity of ciclacillin and other penicilline(author's transl)].
    Baier R; Puppel H
    Med Klin; 1975 Jan; 70(1):24-6. PubMed ID: 164612
    [No Abstract]   [Full Text] [Related]  

  • 45. Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.
    Skov R; Frimodt-Moller N; Menday P; Espersen F
    Int J Antimicrob Agents; 2005 Mar; 25(3):198-204. PubMed ID: 15737512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro interaction between an ampicillin-colistin combination and ampicillin-resistant Escherichia coli].
    Coste M; Escoula L
    Can J Microbiol; 1983 Dec; 29(12):1650-2. PubMed ID: 6370395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Application of ampicillin-cloxacillin (Viccillin S Meiji) in the field of urology].
    Ishigami J; Hara S; Mita T
    Jpn J Antibiot; 1969 Oct; 22(5):372-7. PubMed ID: 4903720
    [No Abstract]   [Full Text] [Related]  

  • 48. [Microbial spectrum and microbial resistance in ambulatory and stationary urological patients].
    Weissbach L; Tümmers H; Primavesi CA
    Z Urol Nephrol; 1970 Oct; 63(10):763-71. PubMed ID: 4994620
    [No Abstract]   [Full Text] [Related]  

  • 49. Microbial resistance to antibiotics used to treat urinary tract infections in Mexican children.
    Hernández-Porras M; Salmerón-Arteaga G; Medina-Santillán R
    Proc West Pharmacol Soc; 2004; 47():120-1. PubMed ID: 15633630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic effect of intravenous drip infusion of ampicillin (Pentrex 'Banyu') in urinary tract and intrapelvic infections].
    Fujimori H
    Jpn J Antibiot; 1970 Dec; 23(5):467-70. PubMed ID: 4929090
    [No Abstract]   [Full Text] [Related]  

  • 51. Urinary tract infection in children: incidence of vesicoureteral reflux, imaging studies, and antimicrobial resistance among E. coli.
    Cheng CH; Chiu CH
    Acta Paediatr Taiwan; 2004; 45(6):313-4. PubMed ID: 15868844
    [No Abstract]   [Full Text] [Related]  

  • 52. Proteus infections in a general hospital. I. Biochemical characteristics and antibiotic susceptibility of the organisms. With special reference to proticine typing and the Dienes phenomenon.
    Adler JL; Burke JP; Martin DF; Finland M
    Ann Intern Med; 1971 Oct; 75(4):517-30. PubMed ID: 5209286
    [No Abstract]   [Full Text] [Related]  

  • 53. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 55. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 56. [Sensitivity of Enterobacteriaceae isolated from humans to 6-N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX)].
    Zaremba M; Zukowska-Nytko K; Grala-Kałuzna A; Kacprzak-Wiatr A; Piotrowski J; Kulikowska A; borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):17-26. PubMed ID: 6292593
    [No Abstract]   [Full Text] [Related]  

  • 57. [Resistance of clinical strains of Proteus to various beta-lactam antibiotics].
    Shvidenko IG
    Antibiotiki; 1976 Oct; 21(10):910-4. PubMed ID: 793508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Change in the antibiogram of various often occurring pathogenic bacterial species and the resulting significance of carbencillin].
    Legler F
    Arch Hyg Bakteriol; 1970 Jun; 154(1):28-36. PubMed ID: 4920202
    [No Abstract]   [Full Text] [Related]  

  • 59. [Significance of laboratory data in the choice of antibiotics for the treatment of infections caused by microbes of the genus Proteus].
    Kuznetsova SM; Fomina IP
    Antibiotiki; 1969 May; 14(5):422-6. PubMed ID: 4891716
    [No Abstract]   [Full Text] [Related]  

  • 60. Urinary tract infection.
    Robertson MH
    Br Med J; 1968 Oct; 4(5623):121-2. PubMed ID: 4880258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.